Literature DB >> 12931889

Treatment of contaminated soil with phosphorus and manganese oxide reduces lead absorption by Sprague-Dawley rats.

Ganga M Hettiarachchi1, Gary M Pierzynski, Fredrick W Oehme, Osman Sonmez, James A Ryan.   

Abstract

This study was conducted to determine the extent of Pb absorption into young rats (Rattus norvegicus var. Sprague-Dawley) fed untreated Pb-contaminated soil or Pb-contaminated soil treated with two different sources of P and P + Mn oxide. Data were compared from an in vitro, physiologically based extraction test (PBET) with the animal data to support the validity of the in vitro test to assess bioavailable Pb from a treated Pb-contaminated soil. Soil with a total Pb concentration of 2290 mg kg(-1) was used. Rats were fed 19 different test diets for 21 consecutive days. The test diets represented 95 g AIN93G rat meal kg(-1) diet with varying proportions of silica sand or soil to provide low, medium, or high doses of Pb from either Pb acetate, treated, or untreated soil. Blood, liver, kidney, and bone Pb concentrations were examined. For all four tissues, Pb concentrations for the Pb acetate groups were significantly higher than concentrations for all the soil groups. In general, either triple superphosphate (TSP) or phosphate rock (PR) treatments resulted in significant reductions in tissue Pb concentrations compared with untreated soil. Blood and kidney Pb concentrations for the PR + Mn oxide group were significantly lower than those of the PR group at the low and high doses. Relative bioavailability of Pb, as measured in all tissues, was significantly reduced when comparing untreated with amended soil. Correlation between the in vitro and in vivo tests, based on bone and liver tissue, showed that the in vitro test is successful at predicting Pb bioavailability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12931889     DOI: 10.2134/jeq2003.1335

Source DB:  PubMed          Journal:  J Environ Qual        ISSN: 0047-2425            Impact factor:   2.751


  7 in total

1.  Quantifying statistical relationships between commonly used in vitro models for estimating lead bioaccessibility.

Authors:  Kaihong Yan; Zhaomin Dong; Yanju Liu; Ravi Naidu
Journal:  Environ Sci Pollut Res Int       Date:  2015-12-15       Impact factor: 4.223

2.  A screening-level assessment of lead, cadmium, and zinc in fish and crayfish from Northeastern Oklahoma, USA.

Authors:  Christopher J Schmitt; William G Brumbaugh; Gregory L Linder; Jo Ellen Hinck
Journal:  Environ Geochem Health       Date:  2006-06-22       Impact factor: 4.609

3.  Dietary Lead and Phosphate Interactions Affect Oral Bioavailability of Soil Lead in the Mouse.

Authors:  Karen D Bradham; Clay M Nelson; Gary L Diamond; William C Thayer; Kirk G Scheckel; Matt Noerpel; Karen Herbin-Davis; Brittany Elek; David J Thomas
Journal:  Environ Sci Technol       Date:  2019-10-16       Impact factor: 9.028

4.  Relationship between Pb relative bioavailability and bioaccessibility in phosphate amended soil: Uncertainty associated with predicting Pb immobilization efficacy using in vitro assays.

Authors:  Farzana Kastury; Silvia Placitu; John Boland; Ranju R Karna; Kirk G Scheckel; Euan Smith; Albert L Juhasz
Journal:  Environ Int       Date:  2019-07-05       Impact factor: 9.621

5.  Interaction effects of lead on bioavailability and pharmacokinetics of arsenic in the rat.

Authors:  Violet Diacomanolis; Barry N Noller; Jack C Ng
Journal:  Environ Geochem Health       Date:  2013-06-01       Impact factor: 4.609

6.  Bioavailable soil Pb minimized by in situ transformation to plumbojarosite.

Authors:  Ranju R Karna; Matt R Noerpel; Clay Nelson; Brittany Elek; Karen Herbin-Davis; Gary Diamond; Karen Bradham; David J Thomas; Kirk G Scheckel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 12.779

7.  Experimental determination of the oral bioavailability and bioaccessibility of lead particles.

Authors:  Elise Deshommes; Robert Tardif; Marc Edwards; Sébastien Sauvé; Michèle Prévost
Journal:  Chem Cent J       Date:  2012-11-22       Impact factor: 4.215

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.